BOP1: A pivotal prognostic biomarker in clear cell renal cell carcinoma uncovered through integrated bulk and single-cell sequencing

Asian J Surg. 2024 Nov 28:S1015-9584(24)02492-8. doi: 10.1016/j.asjsur.2024.10.159. Online ahead of print.

Authors

Wenyu Wang¹, Hongquan Liu¹, Xin Ma¹, Jian Ma²

Affiliations

¹ Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
² Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China. Electronic address: jma1980@126.com.

PMID: 39613603
DOI: 10.1016/j.asjsur.2024.10.159

No abstract available

Keywords: BOP1; Biomarker; Prognosis; Tumor immune microenvironment; ccRCC.

Publication types

Letter